EDONAX IV INJ

EDONAX IV INJ contains Zoledronic Acid, a potent bisphosphonate used to treat osteoporosis, Paget's disease, and bone metastases in cancer patients. This intravenous formulation works by inhibiting bone resorption and strengthening bone density. Administered as an annual or periodic infusion, it helps reduce fracture risk and manage hypercalcemia associated with malignancy. Suitable for patients who cannot tolerate oral bisphosphonates or require more intensive bone protection. Always use under medical supervision with proper hydration and monitoring of renal function and electrolytes.